Clinical Trial Update: SLN12140 in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SLN12140 in adults with paroxysmal nocturnal hemoglobinuria in China; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• SLN12140

Snippet

Sponsor: Linno Pharmaceuticals, Inc. | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 | Status: NOT_YET_RECRUITING